SCHEMBL7861452

SCHEMBL7861452

O=C(O)C#Cc1cc2c(cc1Br)OCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.39
ALDH1A1 P00352 4/20 0.39
MAPK1 P28482 2/20 0.39
PKM P14618 1/20 0.37
CTNNB1 P35222 1/20 0.36
WNT3A P56704 1/20 0.36
SRD5A2 P31213 1/20 0.35
MAPT P10636 2/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 6/20 0.34
ATM Q13315 1/20 0.34
MEN1 O00255 5/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
POLB P06746 2/20 0.33
HPGD P15428 2/20 0.33
HTT P42858 1/20 0.33
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7868091 0.73 AOC3 (0.33) CYP1A2CYP3A4CYP2C19KMT2AMEN1
SCHEMBL5379969 0.71 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1MAPK1PKMCTNNB1
SCHEMBL3739271 0.71 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1MAPK1MAPTCYP3A4
SCHEMBL7216296 0.69 SMN1; SMN2 (0.73) SMN1; SMN2ALDH1A1MAPK1PKMCTNNB1
SCHEMBL30617194 0.69 SMN1; SMN2 (0.73) SMN1; SMN2ALDH1A1MAPK1PKMCTNNB1
SCHEMBL1751672 0.69 AHR (0.53) SMN1; SMN2ALDH1A1MAPK1PKMMAPT
SCHEMBL29061284 0.67 CYP3A4 (0.44) SMN1; SMN2ALDH1A1MAPK1PKMCTNNB1
SCHEMBL9016652 0.65 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1MAPK1PKMMAPT
SCHEMBL11832759 0.65 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1MAPK1PKMMAPT
SCHEMBL30513558 0.64 CYP3A4 (0.46) SMN1; SMN2ALDH1A1MAPK1PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1342156-A Inhibition and treatment of hepatitis B virus and flavivirus by helioxanthin and its analogs UNIV YALE (US) 2002-03-27 CN disclosed
US-6306899-B1 VIRICIDES YALE UNIVERSITY 2001-10-23 US disclosed
EP-1107961-A1 INHIBITION AND TREATMENT OF HEPATITIS B VIRUS AND FLAVIVIRUS BY HELIOXANTHIN AND ITS ANALOGS YALE UNIVERSITY (US) 2001-06-20 EP disclosed
WO-2000010991-A1 INHIBITION AND TREATMENT OF HEPATITIS B VIRUS AND FLAVIVIRUS BY HELIOXANTHIN AND ITS ANALOGS YALE UNIVERSITY (US) 2000-03-02 WO disclosed